205 related articles for article (PubMed ID: 31338651)
21. Amide proton transfer-weighted imaging of pediatric brainstem glioma and its predicted value for H3 K27 alteration.
Cheng D; Zhuo Z; Zhang P; Qu L; Duan Y; Xu X; Xie C; Liu X; Haller S; Barkhof F; Zhang L; Liu Y
Acta Radiol; 2023 Nov; 64(11):2922-2930. PubMed ID: 37722801
[TBL] [Abstract][Full Text] [Related]
22. Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy.
Jiang S; Eberhart CG; Lim M; Heo HY; Zhang Y; Blair L; Wen Z; Holdhoff M; Lin D; Huang P; Qin H; Quinones-Hinojosa A; Weingart JD; Barker PB; Pomper MG; Laterra J; van Zijl PCM; Blakeley JO; Zhou J
Clin Cancer Res; 2019 Jan; 25(2):552-561. PubMed ID: 30366937
[TBL] [Abstract][Full Text] [Related]
23. Amide proton transfer-weighted MRI in distinguishing high- and low-grade gliomas: a systematic review and meta-analysis.
Suh CH; Park JE; Jung SC; Choi CG; Kim SJ; Kim HS
Neuroradiology; 2019 May; 61(5):525-534. PubMed ID: 30666352
[TBL] [Abstract][Full Text] [Related]
24. Prediction of H3K27M-mutant brainstem glioma by amide proton transfer-weighted imaging and its derived radiomics.
Zhuo Z; Qu L; Zhang P; Duan Y; Cheng D; Xu X; Sun T; Ding J; Xie C; Liu X; Haller S; Barkhof F; Zhang L; Liu Y
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4426-4436. PubMed ID: 34131804
[TBL] [Abstract][Full Text] [Related]
25. Fully automated analysis combining [
Paprottka KJ; Kleiner S; Preibisch C; Kofler F; Schmidt-Graf F; Delbridge C; Bernhardt D; Combs SE; Gempt J; Meyer B; Zimmer C; Menze BH; Yakushev I; Kirschke JS; Wiestler B
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4445-4455. PubMed ID: 34173008
[TBL] [Abstract][Full Text] [Related]
26. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
[TBL] [Abstract][Full Text] [Related]
27. Amide Proton Transfer-weighted 7-T MRI Contrast of Myelination after Cuprizone Administration.
Lee DW; Heo H; Woo DC; Kim JK; Lee DH
Radiology; 2021 May; 299(2):428-434. PubMed ID: 33724064
[TBL] [Abstract][Full Text] [Related]
28. Amide proton transfer (APT) and magnetization transfer (MT) in predicting short-term therapeutic outcome in nasopharyngeal carcinoma after chemoradiotherapy: a feasibility study of three-dimensional chemical exchange saturation transfer (CEST) MRI.
Liu W; Wang X; Xie S; Liu WV; Masokano IB; Bai Y; Chen J; Zhong L; Luo Y; Zhou G; Li W; Pei Y
Cancer Imaging; 2023 Sep; 23(1):80. PubMed ID: 37658446
[TBL] [Abstract][Full Text] [Related]
29. Three-dimensional turbo-spin-echo amide proton transfer-weighted mri for cervical cancer: A preliminary study.
He YL; Li Y; Lin CY; Qi YF; Wang X; Zhou HL; Yang JJ; Xiang Y; Xue HD; Jin ZY
J Magn Reson Imaging; 2019 Oct; 50(4):1318-1325. PubMed ID: 30859696
[TBL] [Abstract][Full Text] [Related]
30. Applying protein-based amide proton transfer MR imaging to distinguish solitary brain metastases from glioblastoma.
Yu H; Lou H; Zou T; Wang X; Jiang S; Huang Z; Du Y; Jiang C; Ma L; Zhu J; He W; Rui Q; Zhou J; Wen Z
Eur Radiol; 2017 Nov; 27(11):4516-4524. PubMed ID: 28534162
[TBL] [Abstract][Full Text] [Related]
31. Assessment of Early Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer Using Amide Proton Transfer-weighted Chemical Exchange Saturation Transfer MRI: A Pilot Study.
Zhang S; Rauch GM; Adrada BE; Boge M; Mohamed RMM; Abdelhafez AH; Son JB; Sun J; Elshafeey NA; White JB; Musall BC; Miyoshi M; Wang X; Kotrotsou A; Wei P; Hwang KP; Ma J; Pagel MD
Radiol Imaging Cancer; 2021 Sep; 3(5):e200155. PubMed ID: 34477453
[TBL] [Abstract][Full Text] [Related]
32. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
[TBL] [Abstract][Full Text] [Related]
33. CEST2022: Amide proton transfer-weighted MRI improves the diagnostic performance of multiparametric non-contrast-enhanced MRI techniques in patients with post-treatment high-grade gliomas.
Huang Q; Wu J; Le N; Shen Y; Guo P; Schreck KC; Kamson D; Blair L; Heo HY; Li X; Li W; Sair HL; Blakeley JO; Laterra J; Holdhoff M; Grossman SA; Mukherjee D; Bettegowda C; van Zijl P; Zhou J; Jiang S
Magn Reson Imaging; 2023 Oct; 102():222-228. PubMed ID: 37321378
[TBL] [Abstract][Full Text] [Related]
34. Reproducibility of 3 T APT-CEST in Healthy Volunteers and Patients With Brain Glioma.
Wamelink IJHG; Kuijer JPA; Padrela BE; Zhang Y; Barkhof F; Mutsaerts HJMM; Petr J; van de Giessen E; Keil VC
J Magn Reson Imaging; 2023 Jan; 57(1):206-215. PubMed ID: 35633282
[TBL] [Abstract][Full Text] [Related]
35. Amide proton transfer weighted MRI in differential diagnosis of ovarian masses with cystic components: A preliminary study.
Yu Y; Song X; Zeng Z; Wang L; Zhang L; Zhao H; Zheng Z
Magn Reson Imaging; 2023 Nov; 103():216-223. PubMed ID: 37517767
[TBL] [Abstract][Full Text] [Related]
36. Amide Proton Transfer-Weighted (APTw) Imaging of Intracranial Infection in Children: Initial Experience and Comparison with Gadolinium-Enhanced T1-Weighted Imaging.
Zhang H; Tang X; Lv Y; Hu D; Sun J; Wang Y; Zhou J; Peng Y
Biomed Res Int; 2020; 2020():6418343. PubMed ID: 32509865
[TBL] [Abstract][Full Text] [Related]
37. Evaluating the Role of Amide Proton Transfer (APT)-Weighted Contrast, Optimized for Normalization and Region of Interest Selection, in Differentiation of Neoplastic and Infective Mass Lesions on 3T MRI.
Debnath A; Gupta RK; Singh A
Mol Imaging Biol; 2020 Apr; 22(2):384-396. PubMed ID: 31228076
[TBL] [Abstract][Full Text] [Related]
38. Differentiation of fibroadenomas versus malignant breast tumors utilizing three-dimensional amide proton transfer weighted magnetic resonance imaging.
Zhang N; Kang J; Wang H; Liu A; Miao Y; Ma X; Song Q; Zhang L; Wang J; Shen Z; Xu X
Clin Imaging; 2022 Jan; 81():15-23. PubMed ID: 34597999
[TBL] [Abstract][Full Text] [Related]
39. Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumors.
Zhou J; Zaiss M; Knutsson L; Sun PZ; Ahn SS; Aime S; Bachert P; Blakeley JO; Cai K; Chappell MA; Chen M; Gochberg DF; Goerke S; Heo HY; Jiang S; Jin T; Kim SG; Laterra J; Paech D; Pagel MD; Park JE; Reddy R; Sakata A; Sartoretti-Schefer S; Sherry AD; Smith SA; Stanisz GJ; Sundgren PC; Togao O; Vandsburger M; Wen Z; Wu Y; Zhang Y; Zhu W; Zu Z; van Zijl PCM
Magn Reson Med; 2022 Aug; 88(2):546-574. PubMed ID: 35452155
[TBL] [Abstract][Full Text] [Related]
40. Fluid suppression in amide proton transfer-weighted (APTw) CEST imaging: New theoretical insights and clinical benefits.
Schüre JR; Casagranda S; Sedykh M; Liebig P; Papageorgakis C; Mancini L; Bisdas S; Nichelli L; Pinter N; Mechtler L; Jafari R; Boddaert N; Dangouloff-Ros V; Poujol J; Schmidt M; Doerfler A; Zaiss M
Magn Reson Med; 2024 Apr; 91(4):1354-1367. PubMed ID: 38073061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
